OT mobile menu

Search form


Breast Cancer Targets

Treating Bone Loss in Breast Cancer

A new study has identified how bones get damaged from breast cancer and researchers are developing a new drug to mitigate this problem. Image © JKSippapas/Shutterstock.com


Breast Cancer Targets

A recent analysis of 360 primary breast cancer genomes has identified some potentially important cancer-driving mutations found within noncoding genomic regions.

Comprehensive sequencing for all breast cancer genes may provide complete relevant genetic information for Ashkenazi Jewish patients.

Researchers have discovered new associations between breast and ovarian cancer and genes that had not been previously detected, and which may help guide treatment decisions in the future.

The 70-gene test could aid clinicians and patients in determining the optimal treatment course for breast cancer patients with a very low risk of death from the disease.

A new clinical trial is recruiting to determine whether a breath testing device can aid in the diagnosis of breast cancer.

Results from a nationwide clinical trial, which were presented at the 2017 ASCO Annual Meeting, indicate that adding pembrolizumab to standard therapy before surgery offers the potential for improving outcomes in this patient population.

Atezolizumab was approved for treating patients with metastatic non–small-cell lung cancer who experienced disease progression during or following platinum-containing chemotherapy. Now, it turns out this agent may have a role in combating breast cancer.


Subscribe to Breast Cancer Targets on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.